DURATION: 60 MIN
Experts provide a deep dive into what Health Technology Assessment (HTA) agencies do and the types of literature reviews they do.
As the focus on evidence-based decision-making in healthcare has increased, the role and scope of Health Technology Assessment (HTA) has evolved. The rising number of new pharmaceuticals, medical devices, and other health innovations, along with their novelty and increasing complexity, have led to an increased demand for assessment. How evidence synthesis fits in with Cost Effectiveness Analysis and Budget Impact Assessment and their current challenges with literature review use to support HTAs is discussed.
Key Topics Include:
- Ensuring speed, accuracy, and quality while dealing with information overload and time constraints.
- Employing automation to improve literature reviews and processes.
- The relevance of evidence synthesis.
- What is admissible in terms of AI-enabled technologies for assessments?
Presenters:
Chris Waters-Banker, PhD
Director
Consulting Operations
Maple Health Group, LLC
Maria Arregui, PhD
Assistant Director
Evidence Synthesis & Modeling
Xcenda
Rajshree Pandey, PhD, MPH
Associate Director
Curta Inc.
Lee-Anne Bourke, BSc, MLIS
Account Executive
Evidence Partners
Patti Peeples, PhD, RPh
President & Founder
The Peeples Collaborative